Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Recruitment Status: Authorised-recruitment may be ongoing or finished"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Prognosis%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Prognosis%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Prognosis%22&type=Subject
PubPharm (44)
1
Optimizing MATRix, a combination of Methotrexate, Ara-C, Thiotepa and Rituximab given as an induction therapy, de-escalated in duration and total drug dose in comparison to the standard induction therapy and both treatments followed by a high dose therapy with autologous stem cell transplantation. The therapy is for patients with newly diagnosed primary lymphoma of the central nervous system. : Optimizing MATRix as remission induction in PCNSL: De-escalated induction treatment in newly diagnosed primary CNS lymphoma – a randomized phase III trial - OptiMATe
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
2
Optimizing MATRix, a combination of Methotrexate, Ara-C, Thiotepa and Rituximab given as an induction therapy, de-escalated in duration and total drug dose in comparison to the standard induction therapy and both treatments followed by a high dose therapy with autologous stem cell transplantation. The therapy is for patients with newly diagnosed primary lymphoma of the central nervous system. : Optimizing MATRix as remission induction in PCNSL: De-escalated induction treatment in newly diagnosed primary CNS lymphoma – a randomized phase III trial - OptiMATe
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
3
A clinical trial to evaluate the effect of the anti-viral drug Valganciclovir in brain tumor patients : A multicenter randomized double-blinded controlled phase 2 study evaluating the efficacy of valganciclovir as add-on therapy in glioblastoma patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
4
High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS lymphoma -randomized phase III trial : High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS lymphoma -randomized phase III trial - MATRix / IELSG43
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
5
A clinical trial to evaluate the effect of the anti-viral drug Valganciclovir in brain tumor patients : A multicenter randomized double-blinded controlled phase 2 study evaluating the efficacy of valganciclovir as add-on therapy in glioblastoma patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
6
High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS lymphoma -randomized phase III trial : High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS lymphoma -randomized phase III trial - MATRix / IELSG43
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
7
A phase I/II Study evaluating the safety and the efficacy of Human T Lymphoid Progenitor (HTLP) injection to accelerate immune reconstitution after umbilical cord blood (UCB) transplantation in adult patients with hematologic malignancies - HTLP-onco-adult : A phase I/II Study evaluating the safety and the efficacy of Human T Lymphoid Progenitor (HTLP) injection to accelerate immune reconstitution after umbilical cord blood (UCB) transplantation in adult patients with hematologic malignancies - HTLP-onco-adult
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
8
A phase I/II Study evaluating the safety and the efficacy of Human T Lymphoid Progenitor (HTLP) injection to accelerate immune reconstitution after umbilical cord blood (UCB) transplantation in adult patients with hematologic malignancies - HTLP-onco-adult : A phase I/II Study evaluating the safety and the efficacy of Human T Lymphoid Progenitor (HTLP) injection to accelerate immune reconstitution after umbilical cord blood (UCB) transplantation in adult patients with hematologic malignancies - HTLP-onco-adult
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
Extension Study of an Investigational Drug, Palovarotene, in the Treatment of Preosseous Flare-ups in Subjects with Fibrodysplasia Ossificans Progressiva (FOP) : A Phase 2, Open-Label Extension, Efficacy and Safety Study of a RAR?-Specific Agonist (Palovarotene) in the Treatment of Preosseous Flare-ups in Subjects with Fibrodysplasia Ossificans Progressiva (FOP)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
10
Extension Study of an Investigational Drug, Palovarotene, in the Treatment of Preosseous Flare-ups in Subjects with Fibrodysplasia Ossificans Progressiva (FOP) : A Phase 2, Open-Label Extension, Efficacy and Safety Study of a RAR?-Specific Agonist (Palovarotene) in the Treatment of Preosseous Flare-ups in Subjects with Fibrodysplasia Ossificans Progressiva (FOP)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Authorised-recruitment may be ongoing or finished
Medienart
44
Aufsätze
44
E-Artikel
44
E-Ressourcen
Zeitschriftentitel
44
WHO International Clinical Trials Registry Plat...
Thema
44
610
Recruitment Status: Authorised-recruitment may ...
44
Study Type: Interventional
14
Phase: Phase 2
10
Phase: Phase 3
2
Medical Condition: A population of malignant tr...
2
Medical Condition: Adult patients (n=10) requir...
2
Medical Condition: Fibrodysplasia Ossificans Pr...
2
Medical Condition: Glioblastoma is an incurable...
2
Medical Condition: Glioblastoma is the most com...
2
Medical Condition: Heart failure with normal le...
2
Medical Condition: Macular oedema affects 29% o...
2
Medical Condition: Mantle cell lymphoma is a no...
2
Medical Condition: Mantle cell lymphoma is a ra...
2
Medical Condition: Myelodysplastic syndrome (MD...
2
Medical Condition: Myocardial infarction. We wi...
2
Medical Condition: Patients suffering from pros...
2
Medical Condition: Patients with newly diagnose...
2
Medical Condition: Patients with recurrent and/...
2
Medical Condition: Poor prognosis inoperable si...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
12
2020-
32
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
38
Englisch
2
Französisch
2
Deutsch
2
Spanisch
Haven't found what you're looking for?
Wird geladen...